WHO ICTRP trial
Efficiency of everolimus for the treatment of kidney transplanted patients…
CTIS2024-513814-37-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-513814-37-00 |
|---|---|
| Public title | Efficiency of everolimus for the treatment of kidney transplanted patients presenting a rejection |
| Scientific title | Efficiency of everolimus for the treatment of kidney transplanted patients presenting a missing self-induced NK-mediated rejection (STARR) - 69HCL17_0706 |
| Primary sponsor | Hospices Civils De Lyon |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes |
| Countries | France |
| Conditions | Renal Transplantation MedDRA version: 21.1Level: PTClassification code: 10038435Term: Renal failure Class: 100000004857;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18] |
| Interventions | Product Name: CERTICAN 0,25 mg, comprimé dispersible, Product Code:PRD490372, Pharmaceutical Form: ORAL SOLUTION, Other descriptive name: , Strength: , Product Name: CERTICAN 0,75 mg, comprimé, Product Code:PRD490301, Pharmaceutical Form… |
| Registration date | Sep 18, 2024 |
| Target size | 20 |
| Secondary IDs | NCT03955172;2019-001849-41 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: